These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1115445)

  • 1. Rifampin and warfarin: a drug interaction.
    Romankiewicz JA; Ehrman M
    Ann Intern Med; 1975 Feb; 82(2):224-5. PubMed ID: 1115445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficulties in anticoagulation management during coadministration of warfarin and rifampin.
    Lee CR; Thrasher KA
    Pharmacotherapy; 2001 Oct; 21(10):1240-6. PubMed ID: 11601670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the interaction of rifampin and warfarin.
    Kim KY; Epplen K; Foruhari F; Alexandropoulos H
    Prog Cardiovasc Nurs; 2007; 22(2):97-100. PubMed ID: 17541320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin.
    Alnewais ME; Landolfa SL; Bean M; Fermo JD
    J Prim Care Community Health; 2023; 14():21501319231197588. PubMed ID: 37750044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex interaction of rifampin and warfarin.
    Almog S; Martinowitz U; Halkin H; Bank HZ; Farfel Z
    South Med J; 1988 Oct; 81(10):1304-6. PubMed ID: 3175736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of rifampin and warfarin.
    Self TH; Mann RB
    Chest; 1975 Apr; 67(4):490-1. PubMed ID: 1122784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of the warfarin-rifampin drug interaction in humans.
    Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases
.
    Shibata S; Takahashi H; Baba A; Takeshita K; Atsuda K; Matsubara H; Echizen H
    Int J Clin Pharmacol Ther; 2017 May; 55(5):449-452. PubMed ID: 28157069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of chronic daily warfarin therapy and rifampin.
    O'Reilly RA
    Ann Intern Med; 1975 Oct; 83(4):506-8. PubMed ID: 1166982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible interaction between ciprofloxacin and warfarin.
    Kamada AK
    DICP; 1990 Jan; 24(1):27-8. PubMed ID: 2301186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management.
    Yang CS; Boswell R; Bungard TJ
    Eur J Clin Pharmacol; 2021 Mar; 77(3):341-348. PubMed ID: 33409685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulants in clinical practice.
    Brozović M
    Semin Hematol; 1978 Jan; 15(1):27-34. PubMed ID: 622584
    [No Abstract]   [Full Text] [Related]  

  • 13. Warfarin-griseofulvin interaction.
    Okino K; Weibert RT
    Drug Intell Clin Pharm; 1986 Apr; 20(4):291-3. PubMed ID: 3698827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A warfarin-piroxicam drug interaction.
    Rhodes RS; Rhodes PJ; Klein C; Sintek CD
    Drug Intell Clin Pharm; 1985; 19(7-8):556-8. PubMed ID: 4028961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating patients' warfarin requirements.
    Jones BR; Baran A; Reidenberg MM
    J Am Geriatr Soc; 1980 Jan; 28(1):10-2. PubMed ID: 7350210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically significant hemorrhage due to warfarin-carbamazepine interaction.
    Denbow CE; Fraser HS
    South Med J; 1990 Aug; 83(8):981. PubMed ID: 2382161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inability to achieve a therapeutic INR value while on concurrent warfarin and rifampin.
    Krajewski KC
    J Clin Pharmacol; 2010 Jun; 50(6):710-3. PubMed ID: 20056800
    [No Abstract]   [Full Text] [Related]  

  • 18. Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli.
    Spangler ML; Saxena S
    Clin Ther; 2010 Jan; 32(1):53-6. PubMed ID: 20171411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
    Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
    Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.